{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:04:19Z","timestamp":1761807859839},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1097\/bor.0000000000000077","type":"journal-article","created":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T01:20:20Z","timestamp":1400548820000},"page":"389-394","source":"Crossref","is-referenced-by-count":4,"title":["The effect of tumor necrosis factor-blockade on new bone formation in ankylosing spondylitis"],"prefix":"10.1097","volume":"26","author":[{"given":"Nigil","family":"Haroon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210128","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3899\/jrheum.110971","article-title":"Aberrant chondrocyte hypertrophy and activation of beta-catenin signaling precede joint ankylosis in ankank mice.","volume":"39","author":"Las Heras","year":"2012","journal-title":"J Rheumatol"},{"key":"R2-6-20210128","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.rdc.2012.08.003","article-title":"Pathophysiology of new bone formation and ankylosis in spondyloarthritis.","volume":"38","author":"Lories","year":"2012","journal-title":"Rheum Dis Clin North Am"},{"key":"R3-6-20210128","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/ng.2007.17","article-title":"Wellcome Trust Case Control Consortium, Australo-Anglo-American Spondylitis Consortium (TASC)Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants.","volume":"39","author":"Burton","year":"2007","journal-title":"Nat Genet"},{"key":"R4-6-20210128","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ng.513","article-title":"Australo-Anglo-American Spondyloarthritis Consortium (TASC)Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci.","volume":"42","author":"Reveille","year":"2010","journal-title":"Nat Genet"},{"key":"R5-6-20210128","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1136\/annrheumdis-2011-201252","article-title":"Effect of nonsteroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort.","volume":"71","author":"Poddubnyy","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R6-6-20210128","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/art.21054","article-title":"Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial.","volume":"52","author":"Wanders","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R7-6-20210128","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/ng.1005","article-title":"A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitis.","volume":"44","author":"Lin","year":"2011","journal-title":"Nat Genet"},{"key":"R8-6-20210128","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/art.33430","article-title":"Radiographic severity in ankylosing spondylitis is associated with polymorphism in large multifunctional peptidase 2 (LMP2) in the SPARCC cohort.","volume":"64","author":"Haroon","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R9-6-20210128","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1002\/art.24888","article-title":"Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis.","volume":"60","author":"Appel","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R10-6-20210128","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","article-title":"Dickkopf-1 is a master regulator of joint remodeling.","volume":"13","author":"Diarra","year":"2007","journal-title":"Nat Med"},{"key":"R11-6-20210128","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/annrheumdis-2011-200216","article-title":"High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis.","volume":"71","author":"Heiland","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R12-6-20210128","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1172\/JCI23738","article-title":"Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis.","volume":"115","author":"Lories","year":"2005","journal-title":"J Clin Invest"},{"key":"R13-6-20210128","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/art.33465","article-title":"Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondyloarthritis.","volume":"64","author":"Poddubnyy","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R14-6-20210128","doi-asserted-by":"crossref","first-page":"R104","DOI":"10.1186\/ar2496","article-title":"The relationship between inflammation and new bone formation in patients with ankylosing spondylitis.","volume":"10","author":"Baraliakos","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"R15-6-20210128","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/art.24132","article-title":"Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation.","volume":"60","author":"Maksymowych","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R16-6-20210128","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/annrheumdis-2011-200208","article-title":"MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis.","volume":"71","author":"van der Heijde","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R17-6-20210128","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/annrheumdis-2013-203643","article-title":"Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells.","volume":"73","author":"Jacques","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R18-6-20210128","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3109\/s10165-009-0166-0","article-title":"Ankylosing enthesitis associated with up-regulated IFN-gamma and IL-17 production in (BXSBNZB) F(1) male mice: a new mouse model.","volume":"19","author":"Abe","year":"2009","journal-title":"Mod Rheumatol"},{"key":"R19-6-20210128","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/art.22372","article-title":"Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis.","volume":"56","author":"Lories","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R20-6-20210128","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-gammat CD3CD4-CD8- entheseal resident T cells.","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat Med"},{"key":"R21-6-20210128","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3899\/jrheum.100925","article-title":"Resolution of inflammation following treatment of ankylosing spondylitis is associated with new bone formation.","volume":"38","author":"Pedersen","year":"2011","journal-title":"J Rheumatol"},{"key":"R23-6-20210128","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3899\/jrheum.080871","article-title":"The natural course of radiographic progression in ankylosing spondylitis: evidence for major individual variations in a large proportion of patients.","volume":"36","author":"Baraliakos","year":"2009","journal-title":"J Rheumatol"},{"key":"R24-6-20210128","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/1529-0131(199812)41:12<2263::AID-ART23>3.0.CO;2-I","article-title":"The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment.","volume":"41","author":"MacKay","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R25-6-20210128","first-page":"67","article-title":"Radiological scoring methods for ankylosing spondylitis: a comparison between the Bath Ankylosing Spondylitis Radiology Index and the modified Stoke Ankylosing Spondylitis Spine Score.","volume":"25","author":"Salaffi","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"R26-6-20210128","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10067-009-1290-0","article-title":"Comparison of the Bath Ankylosing Spondylitis Radiology Index and the modified Stoke Ankylosing Spondylitis Spine Score in Turkish patients with ankylosing spondylitis.","volume":"29","author":"Baskan","year":"2010","journal-title":"Clin Rheumatol"},{"key":"R27-6-20210128","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/art.24425","article-title":"Development of a radiographic scoring tool for ankylosing spondylitis only based on bone formation: addition of the thoracic spine improves sensitivity to change.","volume":"61","author":"Baraliakos","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R28-6-20210128","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/acr.22083","article-title":"Development and validation of the spondyloarthritis radiography module for calibration of readers using the modified stoke ankylosing spondylitis spine score.","volume":"66","author":"Maksymowych","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R29-6-20210128","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.38070","article-title":"The impact of tumor necrosis factor alpha inhibitors on radiographic progression in ankylosing spondylitis.","volume":"65","author":"Haroon","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R30-6-20210128","first-page":"60","article-title":"Retardation of ossification of the lumbar vertebral column in ankylosing spondylitis by means of phenylbutazone.","volume":"5","author":"Boersma","year":"1976","journal-title":"Scand J Rheumatol"},{"key":"R32-6-20210128","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1002\/art.23901","article-title":"Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis.","volume":"58","author":"van der Heijde","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R33-6-20210128","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1136\/ard.2004.033472","article-title":"Radiographic progression in patients with ankylosing spondylitis after 2years of treatment with the tumour necrosis factor alpha antibody infliximab.","volume":"64","author":"Baraliakos","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R34-6-20210128","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/rheumatology\/kem166","article-title":"Radiographic progression in patients with ankylosing spondylitis after 4yrs of treatment with the anti-TNF-alpha antibody infliximab.","volume":"46","author":"Baraliakos","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"R35-6-20210128","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/annrheumdis-2012-202698","article-title":"Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8years in patients with ankylosing spondylitis.","volume":"73","author":"Baraliakos","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R36-6-20210128","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/art.20852","article-title":"Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).","volume":"52","author":"van der Heijde","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R37-6-20210128","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/art.21913","article-title":"Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.","volume":"54","author":"van der Heijde","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R38-6-20210128","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/ard.2007.078139","article-title":"Efficacy and safety of up to 192weeks of etanercept therapy in patients with ankylosing spondylitis.","volume":"67","author":"Davis","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R39-6-20210128","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1002\/art.23969","article-title":"Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial.","volume":"58","author":"Inman","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R40-6-20210128","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/annrheumdis-2012-203201","article-title":"Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, part 1.","volume":"73","author":"Sieper","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R41-6-20210128","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/art.24408","article-title":"Clinical and imaging efficacy of infliximab in HLA-B27-positive patients with magnetic resonance imaging-determined early sacroiliitis.","volume":"60","author":"Barkham","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R42-6-20210128","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/annrheumdis-2012-202389","article-title":"Similar response rates in patients with ankylosing spondylitis and nonradiographic axial spondyloarthritis after 1year of treatment with etanercept: results from the ESTHER trial.","volume":"72","author":"Song","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R43-6-20210128","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.3899\/jrheum.091043","article-title":"CANDLE Study GroupLow-dose infliximab (3mgkg) significantly reduces spinal inflammation on magnetic resonance imaging in patients with ankylosing spondylitis: a randomized placebo-controlled study.","volume":"37","author":"Maksymowych","year":"2010","journal-title":"J Rheumatol"},{"key":"R44-6-20210128","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/art.21588","article-title":"Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data.","volume":"53","author":"Baraliakos","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R45-6-20210128","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/art.20977","article-title":"Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept.","volume":"52","author":"Baraliakos","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R46-6-20210128","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/annrheumdis-2011-200859","article-title":"Suppression of inflammation and effects on new bone formation in ankylosing spondylitis: evidence for a window of opportunity in disease modification.","volume":"72","author":"Maksymowych","year":"2013","journal-title":"Ann Rheum Dis"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T19:55:31Z","timestamp":1716753331000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201407000-00006"}},"subtitle":["what is the evidence?"],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000077","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}